Stock Analiz

X4 Pharmaceuticals, Inc (XFOR) stock forecast and price target

Price $3.12 · data as of November 13, 2026

12-month price target

Average target$11.60
Upside / downside+271.8%
Analysts5
ConsensusStrong buy
Low $10.00Average $11.60High $13.00

Gold marker: average target · white marker: today’s price ($3.12)

Analyst ratings

Strong buy 0Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.64+65.6%$17M
Next fiscal year
ends December 31, 2027
$-0.77−19.3%$12M
Next quarter
ends December 31, 2026
$-0.21+4.6%$3M
Quarter after
ends March 31, 2027
$-0.19−18.8%$2M

Consensus of the analysts covering X4 Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the X4 Pharmaceuticals stock price target?

The average 12-month target from 5 analysts is $11.60, 271.8% above the current price of $3.12 Targets range from $10.00 to $13.00.

Is X4 Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is X4 Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.64 for the fiscal year ending December 31, 2026 and $-0.77 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.